Looks like people won’t be seeing much of the tweets of Martin Shkreli. On Sunday afternoon, Twitter suspended Martin Shkreli’s account, subsequent to his constant harassment against Lauren Duca.
BBC recently reported that the social media platform had confirmed that Martin Shkreli’s suspension was related to the said harassment. On the other hand, Twitter has yet to release a statement regarding the issue.
The Root of Mark Shkreli Twitter Suspension
Martin Shkreli previously invited freelance reporter Lauren Duca to Donald Trump’s inauguration. The reporter then took a screenshot of the private message and posted it on Twitter with the caption “I would rather eat my own organs.”
Martin Shkreli is an American entrepreneur and pharmaceutical representative of his firm, Turing Pharmaceuticals. Last 2015, Shkreli and his firm was criticized due to a drug price hike.
I would rather eat my own organs pic.twitter.com/IgeCRZqk8w
— Lauren Duca (@laurenduca) January 5, 2017
It would’ve ended right there and then. But of course, everybody knew Martin Shkreli won’t let it pass. Shkreli followed Lauren Duca’s tweet with another post, containing edited images of Duca and himself together.
He even edited his Twitter bio, adding a line that says he has a small crush on the freelance reporter. Shkreli even changed his Twitter profile image into an edited picture of Lauren Duca and her husband; replacing it with his face.
And Martin Shkreli didn’t bother stopping there. The American entrepreneur updated his profile banner with a collage containing photos of Lauren Duca. Even more, Shkreli shared on Twitter that he purchased the domain name, “marrymelauren.com.”
Shkreli’s Twitter followers joined his trend and posted with countless pictures of Lauren Duca and Martin Shkreli.
Martin Shkreli’s Trial
Martin Shkreli caught the attention of the public, after Turing Pharmaceuticals increased Daraprim’s price from $13.50 to $750. Daraprim was widely used as a treatment for AIDS.
Last December, he was arrested for alleged securities fraud. Then on, Shkreli gave up his position as the head of his pharmaceutical firm.
Besides Martin Shkreli’s Twitter suspension, he is also facing a trial that will commence on June 26, 2017.